Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2004

Feb 3, 2004

34519_dirs_2004-02-03_514edd6d-b219-4a5c-b796-b85e598a1362.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-01-30

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-01-30 Common Stock, par value $0.10 per share P 800 $3.89 Acquired 348760 Direct
2004-02-03 Common Stock, par value $0.10 per share P 400 $3.91 Acquired 349160 Direct
2004-02-03 Common Stock, par value $0.10 per share P 1000 $3.91 Acquired 350160 Direct
2004-02-03 Common Stock, par value $0.10 per share P 500 $3.86 Acquired 350660 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.